PGL 0.00% 85.0¢ prospa group limited.

CYT, IMO, could be a good biotech shares to buy. However, IMO,...

  1. 79 Posts.
    CYT, IMO, could be a good biotech shares to buy. However, IMO, it has two weakness:

    (1) CEO, Andrew, knows finance more than science, and may not be able to guide the company into a better shape it could be;

    (2) Cash position is low and this is the reason why they try to get the cash box like Progen.


    However, CYT does have a good point which its Chairman is quite rich to support this company.
 
watchlist Created with Sketch. Add PGL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.